Case Report
Volume: 3 | Issue: 3 | Published: Sep 12, 2019 | Pages: 98 - 101 | DOI: 10.24911/ejmcr/173-1549383905
Erythema multiforme occurring during concomitant chemoradiation for anal canal cancer: a case report
Authors: Aikaterini Angeliki Efstathopoulou , Piercarlo Saletti , MariaCarla Valli
Article Info
Authors
Aikaterini Angeliki Efstathopoulou
Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Piercarlo Saletti
Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
MariaCarla Valli
Radiation Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Publication History
Received: February 06, 2019
Revised: May 08, 2019
Accepted: July 21, 2019
Published: September 12, 2019
Abstract
Background: Multimodality treatment is the mainstay of therapy for patients with locally advanced squamous cell anal cancer. This consistes of concurrent radiation and chemotherapy (including fluoropyrimidines and mitomycin). Several adverse skin reactions are associated with fluoropyrimidines. Case Presentation: Here, we describe the occurrence of an erythema multiforme in a patient treated with radiotherapy and concomitant mitomycin C and capecitabine for anal cancer. Conclusion: We underline the potential cutaneous drug-induced toxicity during pelvic radiotherapy with capecitabine.
Keywords: Anal canal cancer, erythema multiform, chemoradiation, capecitabine, case report, green
